Citigroup’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-170,000
Closed -$15.5M 5636
2024
Q4
$15.5M Hold
170,000
0.01% 1118
2024
Q3
$17.6M Hold
170,000
0.01% 1011
2024
Q2
$16.5M Sell
170,000
-75,000
-31% -$6.92M 0.01% 977
2024
Q1
$22.1M Buy
245,000
+12,000
+5% +$1.02M 0.01% 836
2023
Q4
$18.6M Hold
233,000
0.01% 887
2023
Q3
$16.6M Sell
233,000
-83,800
-26% -$6.27M 0.01% 868
2023
Q2
$24.4M Buy
316,800
+83,800
+36% +$6.49M 0.02% 730
2023
Q1
$17.5M Buy
+233,000
New +$17.3M 0.01% 880
2022
Q2
Sell
-460,000
Closed -$34.9M 6279
2022
Q1
$34.9M Buy
460,000
+50,000
+12% +$3.96M 0.02% 645
2021
Q4
$35M Buy
410,000
+140,000
+52% +$10.9M 0.02% 722
2021
Q3
$20.4M Buy
+270,000
New +$21.4M 0.01% 990
2021
Q2
Sell
-40,000
Closed -$3.15M 6155
2021
Q1
$3.15M Sell
40,000
-80,300
-67% -$6.29M ﹤0.01% 2164
2020
Q4
$10.3M Buy
120,300
+47,200
+65% +$3.9M 0.01% 1529
2020
Q3
$5.64M Sell
73,100
-14,300
-16% -$1.09M ﹤0.01% 1808
2020
Q2
$6.4M Buy
87,400
+19,700
+29% +$1.4M 0.01% 1646
2020
Q1
$4.49M Sell
67,700
-92,400
-58% -$6.52M ﹤0.01% 1770
2019
Q4
$11M Sell
160,100
-5,500
-3% -$375K 0.01% 1414
2019
Q3
$12.2M Buy
165,600
+21,400
+15% +$1.55M 0.01% 1253
2019
Q2
$10.3M Sell
144,200
-17,900
-11% -$1.27M 0.01% 1367
2019
Q1
$11.1M Sell
162,100
-84,300
-34% -$5.45M 0.01% 1204
2018
Q4
$14.7M Sell
246,400
-33,100
-12% -$2.07M 0.01% 999
2018
Q3
$18.7M Buy
279,500
+5,000
+2% +$333K 0.02% 867
2018
Q2
$17.8M Buy
274,500
+52,700
+24% +$3.45M 0.02% 879
2018
Q1
$15.9M Sell
221,800
-737,900
-77% -$53.1M 0.01% 925
2017
Q4
$72.4M Buy
959,700
+102,500
+12% +$7.48M 0.06% 310
2017
Q3
$62.4M Sell
857,200
-29,200
-3% -$2.1M 0.05% 327
2017
Q2
$65.7M Buy
886,400
+242,400
+38% +$18M 0.06% 266
2017
Q1
$47.1M Sell
644,000
-283,700
-31% -$19.9M 0.04% 380
2016
Q4
$60.7M Buy
927,700
+126,300
+16% +$8.66M 0.05% 328
2016
Q3
$59.4M Buy
801,400
+654,200
+444% +$48.4M 0.06% 297
2016
Q2
$10.8M Sell
147,200
-88,000
-37% -$6.27M 0.01% 996
2016
Q1
$16.6M Sell
235,200
-233,600
-50% -$15.5M 0.02% 695
2015
Q4
$31.2M Sell
468,800
-48,500
-9% -$3.23M 0.03% 533
2015
Q3
$32.8M Buy
517,300
+38,100
+8% +$2.49M 0.03% 488
2015
Q2
$31.3M Buy
479,200
+52,600
+12% +$3.57M 0.03% 563
2015
Q1
$29.6M Buy
426,600
+33,500
+9% +$2.32M 0.03% 574
2014
Q4
$27.2M Sell
393,100
-155,700
-28% -$10.5M 0.02% 649
2014
Q3
$35.8M Buy
548,800
+19,300
+4% +$1.27M 0.03% 527
2014
Q2
$36.1M Buy
529,500
+96,100
+22% +$6.44M 0.03% 486
2014
Q1
$28.1M Buy
433,400
+16,100
+4% +$1.01M 0.03% 551
2013
Q4
$27.2M Sell
417,300
-143,000
-26% -$9.15M 0.02% 615
2013
Q3
$33.2M Sell
560,300
-64,000
-10% -$3.79M 0.03% 510
2013
Q2
$35.8M Buy
+624,300
New +$37.1M 0.04% 432

Other funds holding CL

Citigroup's CL Position: Q1 2026 in Review

Citigroup increased its Colgate-Palmolive (CL) stake by 51% in Q1 2026, buying an estimated $37M and bringing the position to 1,227,068 shares worth $105M. The position accounts for 0.04% of the portfolio, ranked #392.

Citigroup first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $167M in Q4 2019. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Citigroup held 1,227,068 shares of Colgate-Palmolive worth $105M as of Q1 2026.
  • Citigroup bought 414,652 Colgate-Palmolive shares in Q1 2026, an estimated $37M.
  • Colgate-Palmolive made up 0.04% of Citigroup's portfolio in Q1 2026, its #392 holding.
  • Citigroup first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Colgate-Palmolive position peaked at $167M in Q4 2019.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.